Xylem Inc. (XYL)

Basic

  • Market Cap

    $29.91B

  • EV

    $31.18B

  • Shares Out

    241.6M

  • Revenue

    $7,364M

  • Employees

    23,000

Margins

  • Gross

    36.9%

  • EBITDA

    15.81%

  • Operating

    9.89%

  • Pre-Tax

    8.62%

  • Net

    8.27%

  • FCF

    7.69%

Returns (5Yr Avg)

  • ROA

    4.5%

  • ROE

    11.14%

  • ROCE

    8.87%

  • ROIC

    8.44%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $129.21

  • P/E

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,019M

  • Net Debt

    $1,265M

  • Debt/Equity

    0.22

  • EBIT/Interest

    14.86

Growth (CAGR)

  • Rev 3Yr

    14.73%

  • Rev 5Yr

    7.18%

  • Rev 10Yr

    6.74%

  • Dil EPS 3Yr

    25.84%

  • Dil EPS 5Yr

    -1.64%

  • Dil EPS 10Yr

    8.62%

  • Rev Fwd 2Yr

    10.18%

  • EBITDA Fwd 2Yr

    15.38%

  • EPS Fwd 2Yr

    10.67%

  • EPS LT Growth Est

    11.95%

Dividends

  • Yield

  • Payout

    47.03%

  • DPS

    $1.32

  • DPS Growth 3Yr

    8.27%

  • DPS Growth 5Yr

    9.46%

  • DPS Growth 10Yr

    10.98%

  • DPS Growth Fwd 2Yr

    9.18%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

5,249

4,876

5,195

5,522

7,364

Total Revenues % Chg.

0.8%

-7.1%

6.5%

6.3%

33.4%

Cost of Goods Sold, Total

3,203

3,046

3,216

3,434

4,647

Gross Profit

2,046

1,830

1,979

2,088

2,717

Selling General & Admin Expenses, Total

1,165

1,158

1,193

1,237

1,757

R&D Expenses

191

187

204

206

232

Other Operating Expenses, Total

1,356

1,345

1,397

1,443

1,989

Operating Income

690

485

582

645

728

Interest Expense, Total

-67

-77

-76

-50

-49

Interest And Investment Income

5

7

7

16

Net Interest Expenses

-62

-70

-69

-34

-49

Income (Loss) On Equity Invest.

3

2

9

Other Non Operating Income (Expenses)

-5

1

-2

1

33

EBT, Excl. Unusual Items

626

418

520

612

712

Restructuring Charges

-53

-54

-10

-19

-72

Merger & Related Restructuring Charges

Impairment of Goodwill

-148

-58

Gain (Loss) On Sale Of Assets

1

2

1

-1

Asset Writedown

-10

-21

-1

-14

-4

Other Unusual Items

-140

EBT, Incl. Unusual Items

416

285

511

440

635

Income Tax Expense

15

31

84

85

26

Earnings From Continuing Operations

401

254

427

355

609

Minority Interest

Net Income

401

254

427

355

609

Net Income to Common Incl Extra Items

401

254

427

355

609

Net Income to Common Excl. Extra Items

401

254

427

355

609

Total Shares Outstanding

180.1

180.4

180.4

180.3

241.6

Weighted Avg. Shares Outstanding

180

180.1

180.2

180.2

217

Weighted Avg. Shares Outstanding Dil

181.2

181.1

181.5

181

218.2

EPS

2.2

1.4

2.4

2

2.8

EPS Diluted

2.2

1.4

2.4

2

2.8

EBITDA

947

736

827

881

1,164